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1 The United States and the United Kingdom approach health care very differently. The
United States has a largely private health insurance system while the United Kingdom has
a public single-payer system. Different histories and contrasting public values have set up
the fundamental systems that each country has today. With the UK’s National Health
Service recent anniversary of 70 years, it is important to look at its costs and benefits and
compare them to systems in other countries. This paper looks into the role of wasteful
spending in health care and asks how pervasive it is within the systems of the United
States and the United Kingdom. Wasteful spending is a problem because it carries a high
opportunity  cost,  unnecessarily  excluding  some  services  in  substitute  for  others.
Throughout this analysis I consider that the United States has a private health system
because,  although  public  single-payers  exist  such  as  Medicare  and  Medicaid,  the
dominant  insurance  scheme  is  through  the  employer  and  non-group  coverage.  The
United Kingdom has a public supported single-payer system which asserts bargaining
power  and  heavier  regulation  than  in  the  United  States.  With  the  resources  and
definitions I use to explain wasteful spending, I show that both countries’ health systems
have waste but the United States has more evident waste with respect to the UK.
2 In 2017 the OECD published a 300-page report to illustrate the prevalence of wasteful
spending across OECD countries.1 This report considers wasteful expenditures those that
bear high costs relative to their benefits. Although the word “wasteful” is used by the
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OECD, I also use the word “excessive” to express that certain procedures are used more
often than medical evidence would recommend; such procedures are used in excess, and
therefore constitute dollars wasted. “Low-value” care is also a term I use throughout the
analysis to portray how value might be produced, even though the costs to benefits ratio
may be exceedingly high. The OECD estimates that about one fifth of health spending
across  the  OECD  is  wasted.2 Their  report  categorizes  wasteful  spending  into  three
different types: wasteful clinical care, operational waste and governance-related waste.3 A
related study, from 2012, by Berwick and Hackbarth, quantified wasteful spending in the
US.4 Their classifications match up to that of  the OECD and therefore I  include their
definitions to aid understanding.
 
The Three Forms of Waste in Health Care
3 The  first  form  of  wasteful  spending  is  wasteful  clinical  care.  Wasteful  clinical  care
includes any spending on treatments that does not significantly improve outcomes. Such
care was either unnecessary, low-value or the final outcome might have been worse than
what another treatment plan would have offered.5 Partially, this problem could be the
consequence of  the  patient  or  provider  having an imperfect  amount  of  information.
Patients  might  have  limited  knowledge  about  their  health  condition  and  related
interventions. In this case they may put too much trust in medicine and their provider’s
ability  to  cure  them,  without  assuming  personal  responsibility.  Without  critically
thinking patients who can evaluate their own care, the provider can, even unknowingly,
take advantage. The provider might be incentivized towards defensive practices and a
roundabout of tests, which will lead to excess. When it leads to low effective treatments
that could have been substituted with more effective ones, this information asymmetry is
wasteful.
4 A collaboration of health specialists identified interventions that are commonly used in
excess.  Such interventions include imaging for lower back pain,  antibiotics for upper
respiratory infection, induction of labor and others.6 The OECD report suggests that such
excessive  interventions  can  be  partly  attributed  to  defensive  medicine.  Financial
incentives that reward fee-for-service may be a contributing factor for over diagnosis and
treatment.7 Although this category has directly to do with the care a patient receives, not
all waste does; some forms of inefficiency, as explained below, create conditions that raise
prices and exclude people from seeking the care they need. A Gallup poll conducted over
the phone to a random sample of American adults found that in 2014,  33 percent of
Americans put off medical care in the past 12 months for reasons of high cost.8 This
percentage indicates a system that struggles to contribute to what is best for the health of
the financially-burdened individuals.
5 The  second  form  of  wasteful  spending,  operational  waste  as  the  OECD  defines,  are
“situations where health care could be produced using fewer or cheaper resources”.9 This
category of spending deals with the functioning of the markets that provide and consume
health care and services. Although this is considered a form of wasteful spending, it is
unlike  wasteful  clinical  spending  because  it  assumes  the  patient  receives  the  right
amount of services.10 Competitive markets are expected to sell and purchase goods at a
certain cost that is both reasonable and fair. Similar to the OECD, Berwick and Hackbarth
address what they call “Pricing Failures” as one of their six forms of waste. They discuss
such failures as the difference between prices in the true market and a “well-functioning”
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market.11 Even if  this category produces the outcomes we desire,  its  prices might be
higher than they should be. On a system-wide level, this prevents money being used for
other purposes, and on the individual level, anyone without the means or assistance to
pay these prices is inevitably harmed.
6 The OECD’s third and final form of wasteful spending is called governance-related waste.
Administration  is  needed  to  run  any  health  care  system,  but  this  category  includes
spending that is  not essential  to the delivery of  health care.12 Countries’  health care
systems  differ  vastly  in  their  complexity,  which  contributes  to  understandable
differences in administrative expenditure. For example, a single-payer system like the
National  Health  Service  has  less  administrative  spending  than the  private  insurance
system in the United States.13 The OECD reported that administrative spending in the US
was 8.2 percent of its total health expenditure in 2014, while in the UK administration as
a percentage of total health expenditure was only 2.4 percent.14 In addition to wasteful
administrative  spending,  this  category  includes  intentional  waste  generated  through
corruption, fraud and abuse. In any large public or private enterprise in which there is
profit we see attempts to take advantage of loopholes and weaknesses in the system. As
the OECD suggests,  increased transparency and common standards of reporting could
help to detect and decrease this form of waste.15
7 The framework of wasteful spending presented by the OECD sets the stage for a critical
analysis of any system of health care. Even though Berwick and Hackbarth concentrate on
the United States, it is feasible to apply their framework to other countries. In the next
section, I will use both resources heavily, along with others, to look comparatively at the
United States and the United Kingdom.
 
Clinical, Operational and Governance-related Waste in
the United States and the United Kingdom
8 The United States devotes almost double the percentage of their GDP to health care than
the average of the OECD countries; in 2015 the US spent 16.8 percent of their GDP on
health versus the 9 percent average for OECD countries.16 Even with this expenditure,
however,  health  outcomes  in  the  US  fall  behind  many  individual  countries  and  the
average OECD rates,  such as  life  expectancy at  birth and the infant  mortality  rate.17
International comparison by The Commonwealth Fund offers comparison between the US
and the UK, which again reveals higher American spending with worse outcomes.18 This
relationship points to a dissociation between higher spending and lower benefits in the
United States’ health care system. Although I concentrate on the effects of health care, it
is not the only factor impacting our health outcomes. A model from the University of
Wisconsin Population Health Institute shows that the influence of clinical care on our
health outcomes bears only 20 percent of the total influence of all health factors; much
more impactful  factors include economic and social  factors such as  employment and
education.19 Even if a health system is well functioning, the health outcomes such as life
expectancy can be determined in many other life style factors. Therefore, I should point
out that while I give my attention to inefficient and high spending in health care, the
objective to obtain a healthier population must be followed from a more dynamic policy
structure that considers health through all of its contributory factors.
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9 In terms of clinical care, the United States’ private system lends itself to a large amount of
waste. Patients get admitted for conditions that are preventable, for example, and care
can be fragmented when doctors and hospitals do not discuss consistent plans for their
patients. Additionally, the threat of malpractice litigation creates defensive medicine and
pay-for-service schemes reward the amount of services over the outcomes they produce.
Berwick and Hackbarth estimate that across the entire US health care system in 2011 at
least $285 billion were wasted between failures of health care delivery, failures of care
coordination and overtreatment.20
10 The OECD published data about the use of diagnostic tests across its member countries. In
2014, the rates of computed tomography (CT) exams ranged from 31.9 exams per 1,000
people in Finland to 254.7 exams per 1,000 people in the United States. The figures are
normalized over 1,000 people to allow for comparison among countries with different
population sizes. The OECD average for CT exams is 131.6 per 1,000 people, and the United
Kingdom falls well below that average at 75.7 per 1,000 people.21 Although the data do not
show a direct indication of wasteful testing across all exams, such great cross-country
variation is one indication of excessive testing in the US particularly.
11 The next form of waste is known as operational waste and is considered to be a failure to
procure  the  least  costly  goods  and services  to  produce  the  same intended outcome.
Berwick and Hackbarth estimate that pricing failures cost the US health care system at
least $84 billion in 2011.22 Inflation measures the increase of the prices of goods and
services, and for all products this is targeted by the US and the UK at 2.0 percent per year.
23 Here  I  exemplify  pricing  failures  through high inflation.  Health cost  inflation can
indicate the stability of health care markets in the US and the UK. The Consumer Price
Index (CPI) is a measure of the price of certain goods within a designated product or
service basket. Chart 1 below displays the change in the CPI for both countries since 1990,
including spending categories of all items and medical care/health prices alone.24 
Image  1002721400007492000057E67688A91336E4935F.emf
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12 This graph shows that prices for goods and services rise over time. Data on the CPI of all
items in the US and the UK show that increases have been consistent. In 2017, the CPI for
all items in the US was 188 percent of (or 1.88 times) its value in 1990, and in the UK was
185 percent. On average, this was an increase of about 3.2 percent per year, the same for
both countries. However, the CPI for health goods and services (defined as “Medical Care”
in the US and “Health” in the UK) both show that health related prices are increasing at a
relatively faster rate. In the US, the “Medical Care” CPI was 292 percent higher than it
was in 1990, and in the UK the “Health” CPI was 224 percent higher than in 1990. The US
had, on average, a 7.1 percent increase per year in the health CPI, and the UK had a 4.6
percent increase per year. Consistently, both countries have a higher inflation rate in
health-related prices than for all products, but the difference between the two CPI’s is
greater in the US.
13 These relationships show instability in the health market. While prices are the product of
many factors, the steeper rise of the health CPI points to a more volatile market in the US.
For the majority of the United States’ health care system prices are unregulated by the
government. This lack of control subjects the prices of medical care and pharmaceuticals
to market forces of supply and demand.25 On the other hand, as a single-payer of health
services  the  NHS  is  guided  by  a  budget (from  2009/10  to  2016/17  the  NHS  budget
increased on average by 1.3 percent per year26) that offers constraints and necessitates
bargaining to hold down prices.
14 The role of  prices specific to the American health care system was written about by
Anderson et al. in their article titled “It’s the Prices, Stupid: Why the United States is so
Different from Other Countries”.27 In the paper they consider the relatively higher input
prices of health care in the United States. They attribute this to higher physician salaries,
more resource-intensive inpatient care and greater inefficiency.28 Their review of studies
on health care payments and their benefits results in a similar conclusion seen in Chart 1.
They claim that prices are the essential drivers for the overall expenditures of countries.
29 The United States, as Chart 1 shows, has a high inflation in health prices, which directly
but  not  independently,  contributes  to  high  spending.  High  prices  come  with  high
opportunity costs; if great sums of money are used for some treatments, other treatments
must be sacrificed. If high value is not derived from those expensive treatments, money is
unnecessarily diverted from other uses, representing a market failure.
15 On a larger scale, there are expenditures involved in operating and renovating health
care facilities that may not be made at the lowest cost. Throughout the UK the public
finance initiative  (PFI)  is  a  scheme to  initiate  public  projects  through private  sector
finance and ownership. For the NHS in England, according to Appleby from Nuffield Trust,
there were 127 schemes of PFI contracts between the NHS, social care and the private
sector in 2016; the value of those deals was nearly £13 billion.30 The wasteful aspect of
PFI’s is that they cost more because of their involvement with the private sector. An
article from 1999 showed that the contracts for hospitals in England under the public
finance initiative cost 18 to 60 percent more than their construction costs.31 Although the
private firms have a responsibility to the public authority that contracts them, they also
have accountability to their shareholders. Therefore, the private lender expects a profit,
and as the article shows, those lenders could gain real returns of 15 to 25 percent per
year.32 Today  the  costs  associated with  the  procurement  of  private  finance  are  still
apparent. According to a report in 2018 from the National Audit Office, PFI deals entered
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since  2013  were  forecasted  to  give  a  return  to  investors of  2  to  4  percent  above
government borrowing.33
16 The PFI schemes help complete projects with a lack of public capital available to the NHS.
Borrowing to construct  hospitals  and health service centers,  which would have been
traditionally a government responsibility in a nationalized NHS, now relies largely on
contracts  with  private  companies.34 In  addition,  the  failure  of  these  public  finance
initiatives is  a  possibility.  For example,  the recent liquidation of  Carillion plc,  which
provided services to fourteen NHS trusts, including the building of two new hospitals,35
shows that financial risk is not avoided through PFI’s. Higher private borrowing rates,
costs and risks incurred by PFI’s show that the NHS is not investing its resources at the
lowest cost and rates available: designating it as a form of operational waste.
17 In  terms  of  the  third  grouping  of  wasteful  spending,  governance-related  waste,  the
United  States  and  the  United  Kingdom  differ.  The  independent  review  of  wasteful
spending conducted by Berwick and Hackbarth on the United States found that combined
administrative  complexity  and  fraud  and  abuse  cost  at  least  $189  billion  in  2011.36
Although there are no such estimates of governance-related waste in the UK, common
measures  can  help  to  describe  the  differences.  The  OECD  report  includes  data  on
administrative spending across the member countries. The United States again comes out
with the highest value: administrative spending in the US was 8.2 percent of its total
health expenditure in 2014. However, the UK spent less on administration as a percent of
total health expenditure than the OECD average (2.4 percent in the UK, and 3.2 percent
average for all OECD countries37). The entire administrative spending of the US, although
high, may not necessarily be wasteful. The US has a very complex health care system and
therefore requires more administration. The comparative administrative spending may
indicate that  the US wastes  money on administration,  but  it  might  simply show the
natural costs of its fragmented care system. Estimates by Berwick and Harkbarth show us
that non-negligible amounts of money are wasted through administrative complexity in
the US: at least $107 billion in waste in 2011.38
18 Figures on combined management and administrative spending in the NHS help compare
these costs. In a report by the Health Committee of the House of Commons in 2010, a
figure shows the cost of management in the NHS between 1996 and 2009. During that
period, the management costs of the NHS as a percent of the NHS budget actually fell
from 5.1 percent in 1996-1997 to 3.0 percent in 2008-2009.39 Similar updated figures are
more difficult to find. An undated estimate from The King’s Fund that combines spending
on administrative and management says that about £8 billion of the £100 billion NHS
budget is spent on management and administration.40 Another report from The King’s
Fund shows that the number of NHS managers fell by 18.8 percent from 2010 to 2017,
while  staff  numbers in other functional  groups,  such as  nurses  and ambulance staff,
increased.41 On the other hand, according to NHS Digital,  the mean annual earnings of
senior managers in NHS Trusts and Clinical Commissioning Groups (CCG’s) in England was
£77,435 in the 12-month period ending in September 2018, 2.2 percent higher the amount
one year before.42 As with the United States, it is hard to designate such high salaries and
spending in the NHS as wasteful. Health care systems serve a large amount of people
constantly, and it would be simplistic to think that less administrative and management
spending, without other structural changes, could lead to a more efficient system. In both
countries,  a  more  in  depth  cost-benefit  analysis  of  spending  on  administration  and
management should be conducted to target its wastefulness.
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19 The  US  and  the  UK’s  health  care  systems  both  have  varying  amounts  of  wasteful
spending. Those who have identified the problem of inefficiency and waste in the US’s
health  care  systems  have  advocated  for  fixes  in  the  legislative  agenda.  The  Patient
Protection  and  Affordable  Care  Act  (ACA),  which  was  passed  in  2010,  made  a  large
legislative effort to expand insurance coverage, improve care delivery and control costs
within the United States’ health care system.
20 To alleviate the magnitude of wasteful and fragmented care, the ACA made big changes to
government-supported  schemes  of  health  care.  Both  Medicare  and  Medicaid  were
amended to incentivize accountable care organizations (ACO’s). Particularly, in Medicare,
providers that organize in ACO’s and meet certain quality markers would be allowed to
share in the cost savings they create.43 The integration of ACO’s into Medicare pushes
forward cost savings as it establishes a shared financial incentive to provide coordinated
and evidence-based care at the lowest cost. 
21 To create better functioning markets for health insurance, the ACA also established the
Medical Loss Ratio to limit the administrative costs and profits of insurance companies.
The provision set a limit on non-medical spending to 15 percent of health insurance
premiums. This means that a private insurance plan is required to use 85 percent of the
premiums consumers pay on “clinical services and quality improvement”.44 Before the
ACA, non-health uses of premiums were regulated only by competition to offer the lowest
cost premiums. Although medical prices have continued to rise since the passing of the
ACA,  the Medical  Loss  Ratio  ensures  that  premiums for  health insurance are largely
earmarked for health purposes rather than for administration. 
22 Compared to the US, the United Kingdom has an important institution in place to resist
wasteful spending and high inflation in health care. Within the provision of clinical care,
the  National  Institute  for  Health  and  Care  Excellence  (NICE),  provides  independent
evidence-based guidance to policy makers and health care providers in England. NICE
works to rigorously review new medicines, technologies and diagnostics. Their reviews
assess new treatments on both their clinical- and cost-effectiveness.45 Amanda Andler, a
consultant physician in England, summarizes that NICE “helps the NHS allocate resources
to maximise health for the greatest number of people”.46 The NICE charter describes the
methodological framework of their reviews, which include calculating Quality Adjusted
Life Years (QALYs) that can be gained by new treatments in relation to the current
treatment.47 Since  NICE  advises  NHS  England,  their  academic  review  process  helps
maintain the low-cost  and effectiveness  of  covered treatment.  The method of  NICE’s
approval  also  ensures  that  producers  and  providers  choose  high-value  health  care
services.
23 High  costs  can  also  be  addressed  more  formally  in  the  UK.  In  March  2014,  the
Procurement, Investment & Commercial Division of the NHS published a report titled
“Combating Inflation – Guidance”. The report advised NHS providers, specifically those in
the  procurement  of  services,  to  “resist  blanket  inflationary  price  increases  from
suppliers”.48 The report explained that NHS budgets at that time were not increasing, and
therefore higher input prices would not be supported. This guidance exemplifies that
resisting  inflation  can  have  great  cost  savings  for  the  NHS;  for  example,  Central
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Manchester University Hospitals NHS Foundation Trust (CMFT) avoided over £2 million in
inflationary increases through such negotiations with suppliers.49
24 Advice like this,  outside of the public providers of health care, such as Medicare and
Medicaid, is unlikely to be public in the United States and might only occur on a small
scale.  The NHS document demonstrates the value of bargaining power throughout an
entire country. A single-payer system like the NHS is able to conduct price negotiations
that a private system like the United States’ cannot. The effects of such price negotiations
can be seen in the CPI, where the UK’s health inflation is much lower than that of the US.
The strength of the UK’s market to manage prices demonstrates too its ability to keep
wasteful operational spending down. Their price negotiations do not appear to be related
to lower quality compared to the US either, as shown by The Commonwealth Fund: their
report  from  2014  ranked  the  UK  the  first  in  quality  care  among  eleven  countries,
including the US, which came in fifth. Similarly, another ranking, by the World Health
Organization, ranked the United Kingdom’s health care system as higher than the United




25 The United Kingdom avoids a lot of sources of wasteful spending that the United States
faces. The United States tends to use excessive testing and clinical care, has high health
costs and has significantly larger rates of administrative spending. Under Affordable Care
Act provisions, including the integration of accountable care organizations, and current
policy attempts to stabilize pharmaceutical prices,51 the United States is attempting to
reduce its inefficiency. Under the Medicare single-payer program, which regulates its
health providers, research has shown that a reduction in payments has kept down health
care inflation.52 The UK increasingly recognizes that previous legislation has brought less-
coordination caused by fragmented care.  For  this  reason,  NHS England is  embracing
integrated care systems similar to ACO’s.53 In terms of administrative spending, the UK’s
Department of Health committed in 2010 to a reduction of administrative spending in the
NHS and reinvestment of those funds to service delivery.54 Worldwide, too, there is an
awareness that low-value spending affects our health care systems. The physician-led
campaign to address wasteful  clinical  spending “Choosing Wisely” was started in the
United States and now has expanded to both England and Wales.55 
26 Although the United States and the UK are working to decrease wasteful spending, more
work needs to be done. The United States needs to address its high prices in relation to
the rest of the world, particularly because it harms people that are increasingly unable to
afford the insurance or the care they need. The UK’s NHS, as it moves into the future from
its 70th year anniversary, needs to support accountable care and integrated budgets to
maximize the population health benefit given a limited NHS budget. It is important that
both countries put greater monitoring on forms of wasteful spending, and important too
is the acceptance of Choosing Wisely recommendations to reduce certain practices that
physicians claim do not produce sufficient benefits. In a time when prices continue to
rise, the population continues to age and chronic diseases threaten to keep us sicker for
longer, it is essential that health care systems address wasteful spending and strive to
produce the equitable and efficient care that people deserve.
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ABSTRACTS
In health care, greater attention in the United States and the United Kingdom is being given to
maximize the benefit of dollars and pounds spent. With the persistent increase in health care
prices  and demographic  changes,  evidence-based  high-value  care  has  become essential.  This
paper examines the nature of wasteful uses of health dollars. The United States wastes money in
its unnecessarily high use of testing and procedures and through its volatile prices that affect
how  health  services  are  managed.  Administrative  costs  in  the  US  are  also  high,  due  to  its
relatively unregulated system. This comparative analysis shows that the UK, on the other hand,
spends less per-capita on health with verifiably better outcomes; nonetheless, the UK too has
sources of low-value spending. More analysis of this problem could help to produce sound public
policy, which would reduce waste and release resources for the improvement of services.
Dans le secteur de la santé, les États-Unis et le Royaume-Uni accordent une plus grande attention
à l'optimisation des dépenses. Avec la hausse des prix et les changements démographiques, les
soins  de  qualité  fondés  sur  des  recherches scientifiques  sont  devenus  essentiels.  Cet  article
examine  la  nature  de  l’utilisation  inutile  des  dépenses  consacrées  à  la  santé.  Les  États-Unis
gaspillent  de l'argent  en utilisant  inutilement des  tests  et  des  procédures  et  en raison de la
volatilité de leurs prix, qui influent sur la gestion des services de santé. Les coûts administratifs
aux États-Unis sont également élevés en raison de son système relativement non réglementé.
Cette analyse comparative montre que le Royaume-Uni, en revanche, dépense moins par habitant
avec de bien meilleurs résultats. Malgré cela, le Royaume-Uni possède également des sources de
dépenses  à  faible  valeur  ajoutée.  Une  analyse  plus  poussée  de  ce  problème pourrait  aider  à
élaborer  une  politique  publique  judicieuse,  qui  réduirait  le  gaspillage  et  dégagerait  des
ressources pour l'amélioration des services.
INDEX
Mots-clés: politique de santé, dépenses de santé, politique comparative, Etats-Unis
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